Mirabella Financial Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Buy
20,625
+3,782
+22% +$51.8K 0.03% 375
2026
Q1
$209K Sell
16,843
-3,260
-16% -$43.8K 0.02% 764
2025
Q4
$253K Buy
20,103
+5,445
+37% +$62.3K 0.02% 522
2025
Q3
$147K Buy
+14,658
New +$132K 0.01% 242
2022
Q2
Sell
-15,128
Closed -$63K 464
2022
Q1
$63K Buy
+15,128
New +$67K 0.01% 468

Other funds holding AMRX

Mirabella Financial Services's AMRX Position: Q2 2026 in Review

Mirabella Financial Services increased its Amneal Pharmaceuticals (AMRX) stake by 22% in Q2 2026, buying an estimated $51.8K and bringing the position to 20,625 shares worth $357K. The position accounts for 0.03% of the portfolio, ranked #375.

Mirabella Financial Services first reported a position in AMRX in Q1 2022 and has held it in 5 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Mirabella Financial Services held 20,625 shares of Amneal Pharmaceuticals worth $357K as of Q2 2026.
  • Mirabella Financial Services bought 3,782 Amneal Pharmaceuticals shares in Q2 2026, an estimated $51.8K.
  • Amneal Pharmaceuticals made up 0.03% of Mirabella Financial Services's portfolio in Q2 2026, its #375 holding.
  • Mirabella Financial Services first reported a position in Amneal Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.